Michael G Ison

Summary

Affiliation: University of Virginia
Country: USA

Publications

  1. ncbi Current research on respiratory viral infections: Fourth International Symposium
    Michael G Ison
    University of Virginia School of Medicine, Charlottesville, VA, USA
    Antiviral Res 55:227-78. 2002
  2. ncbi Current research on respiratory viral infections: Fifth International Symposium
    Michael G Ison
    University of Virginia School of Medicine, Charlottesville, USA
    Antiviral Res 62:75-110. 2004
  3. ncbi Viral infections in immunocompromised patients: what's new with respiratory viruses?
    Michael G Ison
    Division of Infectious Diseases, University of Virginia, Charlottesville, Virginia 22908, USA
    Curr Opin Infect Dis 15:355-67. 2002
  4. ncbi Respiratory viral infections in transplant recipients
    Michael G Ison
    Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Antivir Ther 12:627-38. 2007
  5. ncbi Outcome of influenza infection managed with oseltamivir in lung transplant recipients
    Michael G Ison
    Division of Infectious Diseases and Organ Transplantation, Transplant and Immunocompromised Host Infectious Diseases Service, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA
    J Heart Lung Transplant 27:282-8. 2008
  6. ncbi Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients
    Michael Angarone
    Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    J Natl Compr Canc Netw 6:191-201. 2008
  7. ncbi Prevention and treatment of cancer-related infections
    Brahm H Segal
    Roswell Park Cancer Institute, USA
    J Natl Compr Canc Netw 6:122-74. 2008
  8. ncbi Adenovirus infections in transplant recipients
    Michael G Ison
    Division of Infectious Diseases, Transplant Infectious Diseases Service, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Clin Infect Dis 43:331-9. 2006
  9. ncbi Recovery of drug-resistant influenza virus from immunocompromised patients: a case series
    Michael G Ison
    Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA
    J Infect Dis 193:760-4. 2006
  10. ncbi Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza
    Michael G Ison
    University of Virginia, Charlottesville, VA, USA
    Antivir Ther 8:183-90. 2003

Collaborators

  • F G Hayden
  • Maria Zambon
  • L V Gubareva
  • Corey Casper
  • S L Johnston
  • Oluwadamilola A Adeyemi
  • Brahm H Segal
  • Michael Angarone
  • Lindsey Robert Baden
  • Ken Rolston
  • Erik Dubberke
  • Arthur E Brown
  • Michael Gelfand
  • Earl King
  • Anjana V Yeldandi
  • John N Greene
  • Angelina S The
  • Jose G Montoya
  • Daniel R Kaul
  • Ashley Morris Engemann
  • James I Ito
  • Judith E Karp
  • Emily Mackler
  • Guido Marcucci
  • Alison G Freifeld

Detail Information

Publications11

  1. ncbi Current research on respiratory viral infections: Fourth International Symposium
    Michael G Ison
    University of Virginia School of Medicine, Charlottesville, VA, USA
    Antiviral Res 55:227-78. 2002
  2. ncbi Current research on respiratory viral infections: Fifth International Symposium
    Michael G Ison
    University of Virginia School of Medicine, Charlottesville, USA
    Antiviral Res 62:75-110. 2004
  3. ncbi Viral infections in immunocompromised patients: what's new with respiratory viruses?
    Michael G Ison
    Division of Infectious Diseases, University of Virginia, Charlottesville, Virginia 22908, USA
    Curr Opin Infect Dis 15:355-67. 2002
    ..The respiratory viruses, particularly respiratory syncytial virus, influenza, parainfluenza, adenovirus, and picornaviruses, are increasingly recognized as significant pathogens in these populations...
  4. ncbi Respiratory viral infections in transplant recipients
    Michael G Ison
    Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
    Antivir Ther 12:627-38. 2007
    ..In addition to epidemiological data, recent studies have also advanced our understanding of management of influenza, adenovirus, and RSV infections among transplant recipients...
  5. ncbi Outcome of influenza infection managed with oseltamivir in lung transplant recipients
    Michael G Ison
    Division of Infectious Diseases and Organ Transplantation, Transplant and Immunocompromised Host Infectious Diseases Service, Northwestern University, Feinberg School of Medicine, Chicago, Illinois 60611, USA
    J Heart Lung Transplant 27:282-8. 2008
    ....
  6. ncbi Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients
    Michael Angarone
    Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA
    J Natl Compr Canc Netw 6:191-201. 2008
    ..Fortunately, a growing armamentarium is allowing more effective prophylaxis of these pathogens. This article reviews the epidemiology and prophylactic strategies available for these common opportunistic viral pathogens...
  7. ncbi Prevention and treatment of cancer-related infections
    Brahm H Segal
    Roswell Park Cancer Institute, USA
    J Natl Compr Canc Netw 6:122-74. 2008
  8. ncbi Adenovirus infections in transplant recipients
    Michael G Ison
    Division of Infectious Diseases, Transplant Infectious Diseases Service, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA
    Clin Infect Dis 43:331-9. 2006
    ..Prospective studies are needed to better understand the pathogenesis of and therapeutic options for adenoviral infections in this patient population...
  9. ncbi Recovery of drug-resistant influenza virus from immunocompromised patients: a case series
    Michael G Ison
    Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health Sciences Center, Charlottesville, 22908, USA
    J Infect Dis 193:760-4. 2006
    ..We describe a novel Asp198Asn NA mutation in an influenza B virus and its decreased susceptibility to both oseltamivir and zanamivir...
  10. ncbi Safety and efficacy of nebulized zanamivir in hospitalized patients with serious influenza
    Michael G Ison
    University of Virginia, Charlottesville, VA, USA
    Antivir Ther 8:183-90. 2003
    ..Two rimantadine-resistant viruses emerged during rimantadine monotherapy; no ZNV resistance was observed. Nebulized ZNV appears to be well tolerated in this hospitalized population but further studies are needed to assess its efficacy...
  11. ncbi Fatal adenovirus pneumonia in a person with AIDS and Burkitt lymphoma: a case report and review of the literature
    Oluwadamilola A Adeyemi
    Department of Medicine, Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
    AIDS Read 18:196-8, 201-2, 206-7. 2008
    ....